A20/TNFAIP3 as a brake on intestinal inflammation and tumorigenesis

被引:0
|
作者
Vereecke, L. [1 ]
Silva, S. V. [2 ]
Billiet, T. [3 ]
van Es, J. H. [4 ]
McGuire, C. [1 ]
Slowicka, K. [1 ]
Sze, M. [1 ]
van den Born, M. [4 ]
Hertogh, G. D. [5 ]
Clevers, H. [4 ]
Raes, J. [2 ]
Rutgeerts, P. [3 ]
Vermeire, S. [3 ]
Beyaert, R. [1 ]
van Loo, G. [1 ]
机构
[1] Inflammat Res Ctr, Ghent, Belgium
[2] Dept Microbiol & Immunol, Rega In, Belgium
[3] Dept Clin & Expt Med, Leuven, Belgium
[4] Hubrecht Inst Dev Biol & S, Utrecht, Netherlands
[5] Dept Morphol & Mol Pathol, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
006
引用
收藏
页码:13 / 13
页数:1
相关论文
共 50 条
  • [21] Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis
    Devos, Michael
    Mogilenko, Denis A.
    Fleury, Sebastien
    Gilbert, Barbara
    Becquart, Coralie
    Quemener, Sandrine
    Dehondt, Helene
    Tougaard, Peter
    Staels, Bart
    Bachert, Claus
    Vandenabeele, Peter
    Van Loo, Geert
    Staumont-Salle, Delphine
    Declercq, Wim
    Dombrowicz, David
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (01) : 135 - 145
  • [22] A20 (TNFAIP3) DEFICIENCY IN MYELOID CELLS TRIGGERS RHEUMATOID ARTHRITIS
    Elewaut, Dirk
    Matmati, Mourad
    Jacques, Peggy
    Maelfait, Jonathan
    Verheugen, Eveline
    Kool, Mirjam
    Sze, Mozes
    Geboes, Lies
    Louagie, Els
    Mc Guire, Conor
    Vereecke, Lars
    Chu, Yuanyuan
    Staelens, Steven
    Matthys, Patrick
    Lambrecht, Bart
    Schmidt-Supprian, Marc
    Pasparakis, Manolis
    Beyaert, Rudi
    van Loo, Geert
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [23] Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome
    Braun, F. C. M.
    Grabarczyk, P.
    Moebs, M.
    Braun, F. K.
    Eberle, J.
    Beyer, M.
    Sterry, W.
    Busse, F.
    Schroeder, J.
    Delin, M.
    Przybylski, G. K.
    Schmidt, C. A.
    LEUKEMIA, 2011, 25 (09) : 1494 - 1501
  • [24] Functional genomics identifies tnfaip3/A20 as a diabetes protective gene
    Zammit, N. W.
    Malle, E. K.
    Walters, S. N.
    Goodnow, C. C.
    Grey, S. T.
    DIABETOLOGIA, 2014, 57 : S103 - S103
  • [25] Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL
    Philipp, Claudia
    Edelmann, Jennifer
    Buehler, Andreas
    Winkler, Dirk
    Stilgenbauer, Stephan
    Kueppers, Ralf
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (07) : 1747 - 1750
  • [26] TNFAIP3(A20) genetic alterations in AIDS-related lymphomas
    Lisa Giulino
    Susan Matthew
    Wayne Tam
    Amy Chadburn
    Gianna Ballon
    Sharon Barouk
    Giuseppina Antonicelli
    Lorenzo Leoncini
    Ethel Cesarman
    Infectious Agents and Cancer, 5 (Suppl 1)
  • [27] A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology
    Hirsch, Burkhard
    Gruenbaum, Maria
    Wagner, Florian
    Bi, Yingwen
    Lucka, Lothar
    Du, Ming-Qing
    Stein, Harald
    Duerkop, Horst
    HISTOPATHOLOGY, 2012, 60 (6B) : E19 - E27
  • [28] TNFAIP3 (A20) Genetic Alterations In EBV Associated AIDS Related Lymphomas
    Giulino, Lisa B.
    Mathew, Susan
    Tam, Wayne
    Chadburn, Amy
    Ballon, Gianna
    Barouk, Sharon
    Antonicelli, Giuseppina
    Leoncini, Lorenzo
    Cesarman, Ethel
    BLOOD, 2010, 116 (21) : 351 - 351
  • [29] The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20
    Eunmi Lee
    Maria Ouzounova
    Raziye Piranlioglu
    Minh Thu Ma
    Mustafa Guzel
    Daniela Marasco
    Ahmed Chadli
    Jason E. Gestwicki
    John K. Cowell
    Max S. Wicha
    Khaled A. Hassan
    Hasan Korkaya
    Oncogene, 2019, 38 : 469 - 482
  • [30] Genetic Mutations Associated With TNFAIP3 (A20) Haploinsufficiency and Their Impact on Inflammatory Diseases
    Bagyinszky, Eva
    An, Seong Soo A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)